InsiderTrades

Form 4 for PLSE PULSE BIOSCIENCES, INC.

Accepted 2024-07-09 00:00:00 ET · period of report 2024-07-03 · accession 0001437749-24-022360 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-07-09 2024-07-03 PLSE Zanganeh Mahkam Dir X - OptEx — +60.2K 665.2K +10% —
DM 2024-07-09 2024-07-03 PLSE Zanganeh Mahkam Dir P - Purchase — +60.2K 30.1K New —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-07-03 X A 60,242 — 665,153 D — — (F2) Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions.
2 Derivative Warrant (right to buy) 2024-07-03 P A 30,121 — 30,121 D $11.00 · 2024-07-03 to 2029-07-03 30,121 Common Stock (F1) The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. (F2) Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions.
3 Derivative Warrant (right to buy) 2024-07-03 P A 30,121 — 30,121 D $11.00 · 2024-07-03 to 2029-07-03 30,121 Common Stock (F1) The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. (F2) Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions.